SFRP5 can inhibit the Wnt signaling pathway by binding to Wnt5a, activate nitric oxide synthase in endothelial cells, and relax blood vessels, thereby inhibiting the formation and development of atherosclerotic plaques, reducing the risk of ISR, and playing a protective role in cardiovascular diseases [13]. The gene discussed is WNT5A; the disease is cardiovascular disorder.